Date: Monday, October 6th from 16.00 to 18.00 hrs (GMT+8).
Location: WVPA CONGRESS Kuching, Malaysia.
Venue: Borneo Convention Centre Kuching (BCCK), Meeting Room #12.
KEMIN BIOLOGICS invites our global poultry community to engage in the latest expert discussions addressing best practices to counteract disease challenges threatening animal production worldwide. Join the upcoming global Avian Influenza Summit broadcast live from the World Veterinary Poultry Association Congress in Kuching, Malaysia. In this third edition, global experts will update integrated risk management against emerging Avian Influenza virus (AIV) strains compromising welfare and profitability in your operation:

- AIV clades threatening poultry and humans
- Effective governmental policies
- Integrated risk management
- Best practices for adopting vaccination
Join the free seminar on location in Kuching or through the online livestream. Register now or scroll down for more information about the seminar.
Registration
More about Avian Influenza
Since 2005, Avian Influenza has caused over 500 million birds to be lost globally. Its devastating impact extends beyond domestic and wild birds, threatening livelihoods, food security and public health. The recent shift in the disease’s ecology is also triggering unusual die-offs in wild birds and has led to an alarming increase in mammalian cases. The rapidly evolving nature of avian influenza and changes in its patterns of spread require a review of existing prevention and control strategies. To effectively contain the disease, protect the economic sustainability of the poultry sector and reduce potential pandemic risks, all available tools must be reconsidered, including vaccination. 1

The unique epidemiological and pathobiological characteristics specific to clade 2.3.4.4b viruses are discussed, emphasizing their distinct nature compared to other clades. Wild waterfowl, acting as reservoirs, frequently carry these viruses, posing threats not only to their populations but also to other wild bird species, including endangered ones. Furthermore, an increasing number of clade 2.3.4.4b virus infections in wild or domestic mammalian species raises significant concerns about potential spillover events to humans.2

When it comes to vaccination, a short antigenic distance between vaccines and field strains is essential, requiring rapid updates of vaccines to match circulating strains. Planning vaccination requires selecting the most adequate vaccine type and vaccination scheme. Preventive vaccination should prioritise achieving the highest protection, especially for the most susceptible species in high-risk transmission areas.3 In this context, discussing best practices is the foundation to effectively tackle these major viruses compromising food security and public health globally.
REFERENCES
1. WOAH.org/en/avian-influenza-vaccination-why-it-should-not-be-a-barrier-to-safe-trade/
2. Graziosi et al 2024. Animals 2024, 14(9), 1372
3. FSA Journal 2023;21(10):8271